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The diagnosis and clinical management of diabetes are
ba ed upon the detection and correction of an abnormal
glucose-tolerance test. However, as this test is merely in-
dicative of altered carbohydrate metabolism, 'true' control
of the diabetic state can only be achieved by the accurate
definition and treatment of the aetiological agents re-
ponsible in each individual patient.
The atal Indian diabetic, for example, conforms to a
pattern which is highly suggestive of adrenocortical hyper-
activity. Thus these patients rarely develop ketosis, are
relatively resistant to insulin, are frequently aglycosuric in
the fasting state, and have hirsutes and trunk obesity.
As it is generally accepted that certain diseases have a
racial prevalence, the following study was instituted with
the object of comparing:
(a) The excretion pattern of the 17-hydroxycorticoids
(17 - OHCS) and the 17-ketosteroids (oxosteroids or 17-KS)
in pregnant non-diabetic Indian females during the third
trimester of pregnancy with similar values in the pregnant
atal Indian diabetic.
(b) The effect (if any) of diabetic 'control' on glucocorti-
coid and ketosteroid activity as measured by their ex-
cretory products.
MATERIAL AND METHOD
Twenty Natal Indian diabetic women were admitted to the
antenatal ward for routine investigation and treatment. Of
these, 3 had received no treatment for their diabetes (being
seen for the first time in the 38th week of gestation), 4 were
on tolbutamide, 2 on chlorpropamide and 2 on insulin, and
9 were controlled on diet alone (Table I).
The 39 'controls' were patients of the same racial group
'Date received: 18 September 196 .
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who were hospitalized for conditions other than diabetes,
this having been excluded on the ground of normal
glucose tolerance. Some of the patients regarded as 'normal
pregnancies' were women who had been referred to the
diabetes clinic for investigation because of a family hi tory
of diabetes, but who were found to have normal carbo-
hydrate tolerance. The 10 patients with pre-eclamptic
toxaemia all had mild signs and symptoms (blood pressure
les than 160/ lOO mm.Hg; albuminuria + or less; oedema
+) and most were controlled on bed rest and sedation
alone. The rest of the controls were a miscellaneous group
consisting of 3 cardiac patients; 3 patients with moderately
severe iron-deficiency anaemia; and single cases of placenta
praevia (on conservative treatment), suspected postmaturity,
contact bleeding and premature rupture of membranes.
The diabetic and control groups were matched as regards
age and parity.
Twenty-four-hour specimens of urine were obtained
under identical basal resting conditions. The total 17-
ketosteroids (oxosteroids) were assayed by tha method of
Norymberski et al.' and the 17-hydroxycorticoids by the
method of Appleby et al.' A total of 112 determinations
were performed in the diabetic group and 118 in the
control group. All assays were performed by the same
technician in the Department of Obstetrics and Gynaecol-
ogy, Univer ity of Natal.
RESULTS
17-Ketosteroids (Tables II and III and Fig. 1)
A comparison of the mean 17-ketosteroid excretion ra te
in the two groups shows a similar pattern throughout the
third trimester, with the output in the diabetic group being
greater than that in the control group. Although fluctua-
tions did occur during this period, the mean excretion level
was 11·73 ± 4·6 mg. / 24 hours in the diabetics as opposed
TABLE I. ANALYStS OF 20 NATAL rNDLAN DLABETlCS STUDlED
GIT mg.{100 ml. Mean 3rd trimester
Age 17-KS 17-0HCS Result of
ame in years Parity Fasting 2 hours Treatment value value pregnancy
RA 24 5 100 188 iI 9 ·1 10·2 Live F (7{4)*
P.P. 21 3 90 180 il 11·7 12·4 Live F (8/12)
A.P. 32 4 85 143 Nil 11·1 14·1 Live F (6/14)
P.P. 23 0 81 186 Diet 15·9 18'5 Live F (5/8)
C.R. 27 2 96 173 Diet 15·3 15·9 Live M (8/4)
K.S. 30 2 130 250 Diet 14·5 14·9 Live F (l0{4)
.B. 32 6 122 217 Diet 9·5 10·2 Live F (8/9)
J.G. 27 5 75 195 Diet 4·9 5·5 Live F (6/6)
K.S. 27 1 64 195 Diet 16·8 17·2 Live M (6/10)
D.M. 40 5 140 293 Diet 14·2 14·7 Live F (7/10)
R.O. 32 4 77 144 Diet 7·2 8·7 Live F (5/4)
E.P. 32 6 107 198 Diet 15· I 16·0 Live F (7/2)
C.H. 17 0 93 180 Tolbutamide 13·2 14·8 Live M (5/8)
P.G. 30 6 115 203 Tolbutamide 13·9 14'5 Live M (8/8)
M.S. 26 3 155 197 Tolbutamide 9·2 9·7 Ab conded
D.G. 25 3 210 634 Tolbutamide 1·8 2·9 Stillborn M (5/1)
M. '. 30 3 95 190 Chlorpropamide 15·5 16·0 Live M (7/0)
A.G. 25 I 167 360 Chlorpropamide 7·2 7·5 Live F (8/9)
S. 36 3 122 203 Insulin 9·3 10·8 Live M( 0)
B.M. 30 2 100 213 Insulin 16'2 16·9 Live F (7/10)
• Figures in parenthesis indicate binhweight in lb. and oz.
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to 9'3 ± 4·3 mg./24 hours in the control group. This
difference i tatistically significant (p = < 005).
17-Hydroxycorticoids (Tables Il and III and Fig. 2)
A imilar pattern wa obtained when the mean 17-
hydroxycorticoid excretion rates were compared in the two
group . The mean excretion rate in the diabetic group was
12·6 ± 4·5 mg./24 hours and that of the control group
11·00 ± 6'8 mg.f24 hour. The difference wa found to be
just short of statistical significance (p = > 0,05).
Diabetic Control and 17-Ketosteroid and Hydroxycorticoid
Excretion
A comparison of the degree of diabetic control and the
17-keto teroid excretion rate was studied in an attempt to
determine the relationship (if any) between 'control' (as
judged by the glucose-tolerance test) and adrenal function
(as judged by 17-ketosteroid excretion). Only those patients
who had had a glucose-tolerance test on the same day
on which the urine specimens were collected, were in-
cluded. Although the number of patients analysed was
small, reference to Fig. 3 indicates that the l7-ketosteroid
excretion level was not in any way related to the 2-hour
blood-sugar level. A similar effect was noted when 17-
hydroxycorticoid values were compared.
DISCUSSION
The results of this study therefore confirm the clinical
impre sion'" that some atal Indian diabetics have certain
hyperactive adrenocortical function. The full significance
of these results, however, is more clearly defined when they
are discussed in relation to the following features.
TABLE U. 24-HOUR URINARY EXCRETlO VALUES OF 17-KETOSTEROLDS AND 17-HYDROXYCORTlCOIDS I
20 PREGNA T NATAL INDIAN DIABETICS
28 weeks 32 weeks 34 weeks 36 weeks 38 weeks 40 weeks
TABLE Ill. 24-HOUR URINARY EXCRETION VALUES OF 17-KETOSTEROLDS AND 17-HYDROXYCORTICOIDS fN
33 'CONTROL' PREGNANT ATAL INDfANS
Mean values 0/ 17-ketosteroid and 17-hydroxycorticoid excretion expressed in mg./24 hours





















































































































































































Mean values 0/ 17-ketosteroids and 17-hydroxycorticoids expressed in mg./24 hours
9·6012·15 9·0111·93 6·38 7·70 10'49
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Fig. 2. A comparison of the mean 17-hydroxycorticoid ex-
cretion rate in 20 pregnant diabetics and 33 pregnant
controls.
Individual Assessment
The results of this study are representative of the group
as a whole, but it is essential that patients be considered
individually, for some diabetics may have normal adrenal
function, whereas in others it may be markedly increased.
Dancaster and Jackson' conclude that the output of adrenal
steroids is not significantly altered in diabetics, yet scrutiny
of their results reveals that the mean l7-0HCS was higher
in their White diabetics than in the White controls. Similar
conclusions were published by Jakobson," yet, once again,
the response of urinary 17-ketogenic steroids to the in-
travenous administration of corticotrophin to a group of
his diabetic patients was found to be significantly greater
than in a non-diabetic control group.
Is it therefore apparent that although the mean value
of an excretory product may not be significant when
analysed statistically, individual assessments provide an
entirely different picture, and in the final reckoning it is the
management of the individual which counts.
Pregnancy
The results of adrenal function obtained during preg-
nancy (if based on urinary excretion) may be fallacious,
as long-term hormonal studies have indicated that oestro-
gen decreases the excretion of cortisol and its metabblites.·
Furthermore, it is well known that the elevated levels of
cortisol commonly found during pregnancy are largely
biologically inactive, due to binding with an oestrogen-
induced globulin. Therefore, when one considers adrenal
function during pregnancy, oestrogen metabolism should
also be taken into account, since raised levels of cortical
steroids with adequate oestrogen production may have a
lesser effect on carbohydrate balance than a lower level of
cortical activity with a poor oestrogen supply. In this
regard, the observations of Boulle'· are of interest, as he
found the level of oestrogen excretion to be much lower
in the pregnant Natal Indian diabetic when compared with
patients of the same racial group and duration of
pregnancy. Davis and Plotz" have similarly described an
increased excretion of urinary ketosteroid (androsterone
and etiocholanolone) in the presence of a diminution of
oestrogen synthesis by the placenta in pregnant diabetics.
As androsterone and testosterone are the principal hor-
monal precursors of oestrogen during pregnancy, they
have postulated that the observed biochemical status in
Race
Friedman' and Henrotte et al.· have shown that the
South Indian has a smaller 24-hour excretion of 17-
ketosteroids than a comparable group of White controls.
The socio-economic status of these individuals is of im-
portance, since the decrease of ketosteroid production is
associated with poor nutrition and a reduction in body
size.·
Most of the patients studied by me are of South Indian
stock and come from the lower income and social groups.
Therefore, although the mean l7-ketosteroid excretion in
the diabetic group (11'7 ± 4·6 mg./24 hours) may be well
within the normal limits (12 - 36 mg./24 hours) for
Whites,' comparison with normal pregnant atal Indian
'control' (9'3 ± 4·3 mg./24 hours) indicates that the



































Blood sugar in mg/100 ml (HERBERT AND BOURNE)
Fig. 3. The degree of diabetic control compared with 17-
ketosteroid excretion.
34. 36 38. 40. DURATION
OF PREGNANCY IN WEEKS
Fig. 1. A comparison of the mean 17-ketosteroid excretion
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these patients is probably due to the inbibition of the
enzyme system responsible for this conversion.
It is therefore tempting to postulate that the observed
increased adrenal cortical function found in some of the
pregnant Natal Indian diabetic assumes even greater
significance as an indicator of possible diabetogenic
activity.
Fractionarion of Cortical Steroids
When assessing adrenal function, it is important to
measure as many metabolites as is practical, for the corti-
coids often vary independently of one another-for ex-
ample, patients with Cushing' syndrome have elevated
levels of hydroxycorticoids and normal ketosteroid values,
while in certain cases of hirsutism the reverse is true.
Similarly, during pregnancy a marked increase in the corti-
coids occurs, whereas 17-ketosteroid remains fairly con-
stant. ll ,,, The elevated values for ketosteroid excretion ob-
tained in the present series are once again in keeping with
the clinical impression that these patients have some
hyperactive adrenal function. Thus McKechnie: in a
clinical survey of 100 female diabetics, reported that 74%
had significant hirsutes (sideburns, and excessive hair on
the upper lip, chest and limbs) as oppo ed to 15°!" in a
control group of 93 patients.
The results obtained might have been even more
significant if the total 17-ketosteroids had been frac-
tionated, for it has been shown that the beta-ketonic
fraction (dehydro-isoandrosterone) is markedly increased
in adrenal hyperplasia and other pathological conditions of
the adrenal cortex. Both the beta- and alpha-ketonic
fractions (androsterone, etiocholanolone: II-oxygenated
ketosteroids) are normally not increased during pregnancy."
Diabetic Control and Cortical Activity
It was partly the object of this study to investigate the
effect (if any) of diabetic 'control' on adrenocortical
function. Although the numbers involved are small, refer-
ence to Fig. 3 indicates that there is no apparent
relationship whatsoever between diabetic control (as judged
by the glucose-tolerance test) and cortical activity (as de-
termined by 17-ketosteroid and 17-hydroxycorticoid excre-
tion).· lakobson similarly concluded that the degree of
control of the diabetic state did not significantly affect
adrenocortical function. These observations serve to
illustrate the importance of defining and treating the cause
of the disordered carbohydrate balance, rather than its
symptom-the elevated blood sugar.
'Adrenal Facts and Fancies'
Cope" has recently indicated that the urinary 17-
ketosteroid excretion rate is of little practical value, in that
80% of the estimate is due to other non-specific
chromogens. Furthermore the results depend upon the
accuracy of collection and storage of the specimen, while
the variations which must occur in the hormonal balance
during a 24-hour period have also to be considered. The
same is true of 17-ketogenic steroid excretion. Isotopic
studies, using radioactive labelled tritium, are the most
accurate methods available for assessing the functional
state of the adrenal cortex, but since their use is con-
traindicated during pregnancy, fluorometric determination
of the free 11-hydroxycorticoids in plasma is the best
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alternative. In order to establish the 'true' state of
adrenocortical activity during pregnancy, it would probably
be necessary to base one's findings on the levels of free
cortisol in the blood before and after stimulation, by drugs
such as Synacthen,"
CONCLUSIONS
Based on the results of investigations of adrenocortical
activity in the pregnant Natal Indian diabetic, it can be
concluded that:
1. The pregnant diabetic subject has increased levels of
l7-ketosteroid and 17-hydroxycorticoid excretion when
compared with the pregnant non-diabetic controls.
2. It is important to assess patients individually as only
some diabetics will have evidence of adrenocortical
hyperfunction.
3. Abnormal values should always be based on a com-
parison with normal values obtained in the same racial
group.
4. Adrenocortical function during pregnancy (and
especially the pregnant diabetic) should be studied in
conjunction with oestrogen assays, since the level of free
and therefore biologically active cortisol is directly related
to the degree of binding with an oestrogen-induced
globulin.
5. The suggestion is made that every diabetic should be
screened before the institution of treatment whenever
adrenal hyperactivity is thought to be of some aetiological
significance, since it would appear that 'true' control can-
not be achieved by suppressing the blood-sugar level.
SUMMARY
A study was instituted with the object of comparing adreno-
cortical function, as measured by the urinary excretion pattern
of the 17-hydroxycorticoids and the 17-oxosteroids, in the
pregnant diabetic and non-diabetic Natal Indian. The results
indicate that the individual pregnant diabetic is more liable to
disturbed adrenocortical activity than the non-diabetic control.
The significance in relation to the management of diabetics is
commented upon.
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